This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...